A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects
Clinical trial NCT05254548 · COMPLETED
Trial details
- NCT number
- NCT05254548
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-18
- Primary completion
- 2022-04-13
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.